EE200100333A - Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine - Google Patents

Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine

Info

Publication number
EE200100333A
EE200100333A EEP200100333A EEP200100333A EE200100333A EE 200100333 A EE200100333 A EE 200100333A EE P200100333 A EEP200100333 A EE P200100333A EE P200100333 A EEP200100333 A EE P200100333A EE 200100333 A EE200100333 A EE 200100333A
Authority
EE
Estonia
Prior art keywords
aminopyridine
intermediates
halo
nitro
preparation
Prior art date
Application number
EEP200100333A
Other languages
English (en)
Estonian (et)
Inventor
C. Salazar Diane (Surnud)
Rodriguez Walter
P. Sherbine James
G. Woodward Rick
W. Sledeski Adam
R. Powers Matthew
K. O'brien Michael
Original Assignee
Aventis Pharmaceuticals Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Products Inc. filed Critical Aventis Pharmaceuticals Products Inc.
Publication of EE200100333A publication Critical patent/EE200100333A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200100333A 1998-12-21 1999-12-14 Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine EE200100333A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11307798P 1998-12-21 1998-12-21
PCT/US1999/029643 WO2000037469A2 (en) 1998-12-21 1999-12-14 Process for preparing n6-substituted deaza-adenosine derivatives

Publications (1)

Publication Number Publication Date
EE200100333A true EE200100333A (et) 2002-08-15

Family

ID=22347487

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100333A EE200100333A (et) 1998-12-21 1999-12-14 Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine

Country Status (28)

Country Link
US (1) US6184382B1 (de)
EP (1) EP1175420B1 (de)
JP (1) JP2002533343A (de)
KR (1) KR20010087425A (de)
CN (1) CN1122667C (de)
AP (1) AP1336A (de)
AT (1) ATE235493T1 (de)
AU (1) AU774155B2 (de)
BG (1) BG105624A (de)
BR (1) BR9917088A (de)
CA (1) CA2357760A1 (de)
CZ (1) CZ20012283A3 (de)
DE (1) DE69906392T2 (de)
DK (1) DK1175420T3 (de)
EA (1) EA003645B1 (de)
EE (1) EE200100333A (de)
ES (1) ES2191489T3 (de)
HK (1) HK1041607A1 (de)
HU (1) HUP0105224A3 (de)
ID (1) ID30118A (de)
IL (1) IL143843A0 (de)
NO (1) NO319789B1 (de)
NZ (1) NZ512500A (de)
PL (1) PL349154A1 (de)
PT (1) PT1175420E (de)
SK (1) SK284767B6 (de)
WO (1) WO2000037469A2 (de)
YU (1) YU51401A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03006730A (es) * 1996-12-11 2003-10-24 Aventis Pharma Inc Preparacion de 4-hidroxi-3-nitro-2(1h)-piridona.
KR100446669B1 (ko) * 2002-04-04 2004-09-04 (주) 비엔씨바이오팜 2-(헤테로사이클릭-알킬아미노)피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
US7291603B2 (en) * 2002-07-24 2007-11-06 Ptc Therapeutics, Inc. Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652366A (en) * 1990-09-25 1997-07-29 Rhone-Poulenc Rorer Pharmaceuticals Inc. DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
ES2095960T3 (es) * 1990-09-25 1997-03-01 Rhone Poulenc Rorer Int Compuestos que tienen propiedades antihipertensivas y antiisquemicas.

Also Published As

Publication number Publication date
EA003645B1 (ru) 2003-08-28
NO20013044D0 (no) 2001-06-19
NO20013044L (no) 2001-08-20
JP2002533343A (ja) 2002-10-08
US6184382B1 (en) 2001-02-06
AP1336A (en) 2004-11-30
HUP0105224A2 (en) 2002-06-29
NZ512500A (en) 2003-01-31
KR20010087425A (ko) 2001-09-15
CA2357760A1 (en) 2000-06-29
ATE235493T1 (de) 2003-04-15
CZ20012283A3 (cs) 2001-10-17
AP2001002200A0 (en) 2001-09-30
EA200100697A1 (ru) 2001-12-24
BR9917088A (pt) 2006-01-31
DE69906392D1 (de) 2003-04-30
WO2000037469A2 (en) 2000-06-29
HUP0105224A3 (en) 2003-01-28
WO2000037469A3 (en) 2000-09-14
HK1041607A1 (zh) 2002-07-12
SK9072001A3 (en) 2001-12-03
EP1175420A2 (de) 2002-01-30
PL349154A1 (en) 2002-07-01
ES2191489T3 (es) 2003-09-01
ID30118A (id) 2001-11-08
CN1122667C (zh) 2003-10-01
DE69906392T2 (de) 2004-02-05
IL143843A0 (en) 2002-04-21
PT1175420E (pt) 2003-08-29
AU2181400A (en) 2000-07-12
BG105624A (en) 2002-01-31
CN1333773A (zh) 2002-01-30
AU774155B2 (en) 2004-06-17
NO319789B1 (no) 2005-09-12
EP1175420B1 (de) 2003-03-26
SK284767B6 (sk) 2005-11-03
DK1175420T3 (da) 2003-07-07
YU51401A (sh) 2003-12-31
WO2000037469B1 (en) 2000-11-02

Similar Documents

Publication Publication Date Title
EE200000255A (et) Vähivastaste ühendite valmistamise protsess ja vaheühendid
NO990756D0 (no) FremgangsmÕte for fremstilling av mellomprodukter for florfenikol
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
FI980246A (fi) Menetelmä keittimen käyttämiseksi ja keitin
NO991382L (no) Mellomprodukter og fremgangsmÕte for fremstilling av olanzapin
NO20003454D0 (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
DE69922440D1 (de) Verfahren und Zwischenprodukte zur Herstellung von 2,3-Pyridindicarboxylatderivaten
FI956058A0 (fi) Menetelmä glutaaridialdehydin valmistamiseksi
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
HUP0104278A3 (en) Novel process for the preparation of 7-azaindolyl-3-carboxylic acid and 7-azaindol and their intermediates
NO991672D0 (no) FremgangsmÕte for fremstilling av hydroksaminsyrer
EE200100333A (et) Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
BR9804794A (pt) Processo para prepara-Æo de 1-alquil-4-(2-cloro-3-alcÄxi-4-alquil-sulfonil-benzoil) -5-hidrÄxi-pirazol e compostos relacioonados
FI970426A0 (fi) Menetelmä mikrobinvastaisten kinolonyylilaktaamien valmistamiseksi ja uusia välituotteita
NO990185L (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
EE200000357A (et) Meetod 16ß-arüüloksü-4-asasteroidide valmistamiseks ning vaheühendid
NO20001793L (no) FremgangsmÕte ved fremstilling av azacykloalkylalkanoylpseudotetrapeptider
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
FI971378A (fi) Menetelmiä ja välituotteita 3-aminobentso(b)-atsepinonien valmistusta varten
AR019824A1 (es) Proceso para la preparacion de 2-cloro-3-hidroxipiridina